[Inhaled budesonide in the treatment of COVID-19].

Kluge, S; Nitschmann, S; Scherer, M

[Inhaled budesonide in the treatment of COVID-19]. / Inhalatives Budesonid zur Therapie bei COVID-19.

Kluge, S; Nitschmann, S; Scherer, M.

Kluge S; Zentrum für Anästhesiologie und Intensivmedizin, Klinik für Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland. skluge@uke.de.
Nitschmann S; , Lippetal, Deutschland.
Scherer M; Institut und Poliklinik für Allgemeinmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.

Internist (Berl) ; 62(8): 887-889, 2021 Aug.

Article in German | MEDLINE | ID: covidwho-1287423

Subject(s)

Budesonide; COVID-19; Administration, Inhalation; Bronchodilator Agents/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Budesonide / COVID-19 Limits: Humans Language: German Journal: Internist (Berl) Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google